This disclosure relates to new methods for delivering an aqueous cannabinoidsolution orally forabsorption through the gastrointestinal tract. The composition includes 1)active forms ofcannabinoids and/or purified cannabinoids, 2) Vitamin E TPGS and 3) Water. Theself-emulsifying composition decreases Hepatic First Pass Metabolism andincreasesabsorption of cannabinoids. The composition increases shelf stability and evendistribution ofCannabinoids throughout the solution, improving upon previous oral, aqueouscannabinoiddelivery solutions.